This is the first report on the long-term durability of response among complete responders to mitomycin C chemoablation of low-grade upper tract urothelial carcinoma.

While randomized comparative trials are needed, a relatively new treatment option for upper urinary tract cancers shows promise for lowering long-term recurrence in many patients with low-grade ...

Mitomycin C chemoablation can provide nearly 4 years of response in initial responders to therapy. Mitomycin reverse thermal gel for low-grade upper tract urothelial carcinoma (UTUC) chemoablation ...